Replies to post #536917 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Avoiding RegFD seems an obvious reason why NWBO IR are silent

A public company can always disclose material news publicly. What they can't do is disclose to individuals or via side channels.

DI can say whatever he wants in a PR, though adding it to an 8K is "best practice".

[HappyLibrarian]

How many other JAMA articles get big mainstream coverage on their own?

Unless and until NWBO takes an active role in promoting itself, no one else who is credible is going to do it.

If they are waiting on approval or a partnership or a buyout to communicate with journalists in a meaningful way then we as shareholders can be in for a long, frustrating wait and will just have to remember that now we have full scientific validation of what we hold and can accumulate accordingly.

[biosectinvestor]

It was off their radar. They are no doubt reading all of Adam Feuerstein’s articles. Hopefully they are actually getting the full story. I expect that they will, but there will be a delay and the company should definitely locate advocates who spontaneously supported the trial online and doctors who participated and create a contact list. I presume they have already done this.